LifeStyle
-
GI Innovation's GI-101 selected for government-initiated drug development program
SEOUL -- GI-101, an immunotherapy agent being developed by South Korea's bio-venture company GI Innovation, has been selected for a government-initiated drug development program to receive financial support at clinical stages. GI Innovation said it would get up to seven billion won ($5.5 million) in research support for two years from the Korea Drug Development Fund (KDDF), which supports the investment, nurture and development of promising drugs. KDDF's move is seen as a
9 May 2022
-
Yanolja's cloud solution wing makes strategic investment in India's Innkey
SEOUL -- The cloud solution wing of Yanolja, a leading travel and leisure activity reservation service platform in South Korea, will make a strategic investment in Innkey Infosystems with the conditional acquisition of the India-based service provider of cloud-based hotel management software. Yanolja Cloud said the investment is aimed at expanding its global Software-as-a-Service (Saas) solution business by combining the technology and know-how of the two companies. Innkey provide
4 May 2022
-
Rare ordinance enacted by local assemblymen to protect toad ecosystem
SEOUL -- A rare ordinance has been enacted by local assemblymen in South Korea to protect an ecosystem for the Asiatic toad between their habitat in a mountain and a spawning ground in the middle of a residential area. The Asiatic toad is a species of toad endemic to East Asia. The species is relatively rare on the Korean Peninsula. The Asiatic toad avoids dense forests, but is found in most other habitats, including grasslands, open forests, meadows, and cultivated areas. It pref
26 April 2022
-
World's first prototype floating community in Busan designed to accommodate residents living on ideal eco-village
SEOUL -- The world's first prototype of a floating community to be built in South Korea's southern port city of Busan for a United Nations project to present a solution to ensure climate resilience will be designed to accommodate thousands of residents living on an ideal eco-village where water leisure and daily life harmonize. As the world's coastal cities are increasingly threatened by rising populations and sea levels, the UN is exploring a new approach to building
26 April 2022
-
SK Bioscience's COVID-19 vaccine acquires successful results in final-stage clinical trial
SEOUL -- Based on successful results in final-stage clinical trials at home and abroad, SK Bioscience will seek to apply for state approval to commercialize its COVID-19 vaccine candidate codenamed GBP510 after securing data on its safety by the end of April. SK Bioscience said that GBP510 has produced successful results in phase 3 clinical trials involving 4,037 adults aged 18 or older in South Korea, Thailand, Vietnam, New Zealand, Ukraine, and the Philippines, such as showing e
25 April 2022
-
Daewoong applies for state approval to use Nabota botox for masseteric hypertrophy
SEOUL -- Daewoong Pharmaceutical, a bioengineering company in South Korea, has applied for state approval to use Nabota, a botulinum toxin product developed for the treatment of frown lines, as the treatment of benign masseteric hypertrophy (square jaw) based on the positive results of a final clinical study. Benign masseteric hypertrophy is a relatively uncommon condition that can occur unilaterally or bilaterally. Unilateral- or bilateral hypertrophy of the masseter muscle is c
21 April 2022
-
Singapore's Juniper Biologics secures $600 million licensing deal from Kolon to commercialize cell-mediated gene therapy for degenerative arthritis.
SEOUL -- Juniper Biologics, a Singapore-based developer of novel therapies, has secured a $600 million licensing deal from Kolon Life Science, a biosimilar arm of South Korea's Kolon Group, to develop and commercialize TG-C, the world's first cell-mediated gene therapy for degenerative arthritis. The deal covers the Asia Pacific region, the Middle East and Africa except for South Korea, China, Hong Kong, Macao and Taiwan. Juniper Biologics will be responsible for developing
13 April 2022
-
Cosmax teams up with research institute to commercialize fiber material with cosmetics function
SEOUL -- Cosmax, a cosmetics original development manufacturer in South Korea, teamed up with a domestic research institute to commercialize a functional material that adds cosmetics functions to textiles. The first lineup will be bedding and clothing with cosmetic fibers applied with various cosmetics materials. Cosmax is developing bedding made of cosmetic fibers in partnership with the Korea Dyeing and Finishing Technology Institute (DYETEC), which has cosmetic source technolog
13 April 2022
